How to transfer my Doxepin prescription to Pennsylvania

Last Updated: December 2025

If you’re struggling with sleepless nights and wondering whether you can get help through telehealth, you’re not alone. Millions of Americans are discovering that effective insomnia treatment is now available from the comfort of home—no waiting rooms, no awkward in-person visits at inconvenient times. But can a doctor really prescribe sleep medication through a video call? And is it legal?

The short answer: Yes, in most cases. Telehealth providers can legally prescribe certain insomnia medications across all 50 states, and the process has become more streamlined than ever in 2025. However, the details matter—what medications can be prescribed, which states have specific rules, and whether your situation is appropriate for virtual care.

This guide will walk you through everything you need to know about accessing insomnia treatment through telehealth, from understanding the regulations to knowing what to expect during your virtual appointment.

Understanding Telehealth Prescribing Rules for Sleep Medications

The legality of prescribing sleep medications via telehealth depends primarily on whether the medication is classified as a ‘controlled substance’ by the Drug Enforcement Administration (DEA).

Non-Controlled Sleep Medications: Widely Available via Telehealth

Non-controlled insomnia medications—such as trazodone and low-dose doxepin (Silenor)—can be prescribed through telehealth nationwide with no federal in-person examination requirement. These medications are not classified as controlled substances, making them significantly more accessible through virtual platforms.

The federal Ryan Haight Act of 2008, which requires an in-person exam before prescribing controlled substances online, does not apply to non-controlled medications. This means that as long as a proper telehealth evaluation is conducted, providers can legally prescribe these sleep aids without ever meeting you face-to-face.

What About Controlled Sleep Medications?

Traditional prescription sleep medications like zolpidem (Ambien), eszopiclone (Lunesta), and benzodiazepines are classified as Schedule IV controlled substances. Under normal circumstances, the Ryan Haight Act would require an initial in-person visit before these could be prescribed online.

However, COVID-19 emergency flexibilities temporarily waived this requirement. As of December 2025, the DEA has extended these telehealth prescribing flexibilities through December 31, 2025, marking the third such extension. This means controlled sleep medications can technically be prescribed via telehealth through the end of 2025—though many reputable telehealth platforms choose to focus on non-controlled alternatives due to safety concerns and the uncertain regulatory future.

Important note: New DEA regulations are expected in 2026 that will likely tighten requirements for prescribing controlled substances via telehealth. For this reason, established telehealth providers typically emphasize non-controlled treatment options that will remain accessible regardless of future regulatory changes.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Which Sleep Medications Can Telehealth Providers Prescribe?

Trazodone: The Most Common Telehealth Sleep Aid

Trazodone is an antidepressant frequently prescribed off-label for insomnia. It’s not a controlled substance, making it ideal for telehealth prescribing.

Key facts:

• DEA Schedule: None (unscheduled)
• Typical starting dose: 25-50 mg at bedtime
• How it works: Increases serotonin and has sedating properties
• Supply limits: Can be prescribed for 90 days or more with refills
• Common practice: Providers often start with a 30-day supply to assess effectiveness

Trazodone is particularly useful for people whose insomnia is accompanied by anxiety or mild depression. Side effects are generally manageable and may include morning grogginess, dry mouth, or dizziness.

Doxepin (Silenor): FDA-Approved for Insomnia

Low-dose doxepin (marketed as Silenor) is one of the few medications FDA-approved specifically for insomnia at low doses.

Key facts:

• DEA Schedule: None (unscheduled)
• Typical dose: 3-6 mg at bedtime (much lower than antidepressant doses)
• How it works: Blocks histamine receptors that promote wakefulness
• FDA approval: Specifically indicated for sleep maintenance (staying asleep)
• Refills: Can be prescribed with refills like any non-controlled medication

Doxepin is especially helpful for people who fall asleep easily but wake up in the middle of the night. However, it has contraindications for people with untreated glaucoma or urinary retention.

What About Other Sleep Medications?

Most telehealth platforms, including Klarity Health, focus on non-controlled medications for several reasons:

1. Legal certainty: Non-controlled medications face no federal prescribing restrictions via telehealth
2. Safety profile: Lower abuse potential and withdrawal risks
3. Regulatory stability: Not affected by potential DEA rule changes
4. Clinical appropriateness: Effective for primary insomnia without the dependency concerns of sedative-hypnotics

While some telehealth providers may prescribe controlled sleep medications (like Ambien) under current temporary federal rules, this practice varies by platform and state, and may change when new DEA regulations take effect.

State-by-State Telehealth Rules: What You Need to Know

While federal law sets baseline requirements, individual states have their own telehealth regulations. Here’s what you need to know about key states:

California: Telehealth-Friendly with Evolving Rules

• In-person exam required? No—a telehealth consultation meets California’s ‘good faith exam’ standard
• Latest developments: Assembly Bill 1503 is pending (as of December 2025), which would further expand telehealth by allowing asynchronous evaluations in some cases
• Provider licensing: Practitioners must be licensed in California or hold a valid multi-state compact license

California has been a leader in telehealth expansion, explicitly confirming that video consultations satisfy professional standard-of-care requirements for prescribing.

Texas: Clear Standards for Telemedicine Prescribing

• In-person exam required? No—telemedicine is allowed for new prescriptions if the standard of care is met
• Modality requirements: Two-way audio/video typically required for new prescriptions (unless the patient was seen in person within 90 days)
• NP/PA prescribing: Advanced practice providers can prescribe non-controlled medications under delegation agreements with physicians

Texas clarified its chronic pain telehealth rules in 2023, but these primarily affect controlled substance prescribing. Non-controlled insomnia medications remain fully accessible via telehealth.

Florida: Permissive for Non-Controlled Medications

• In-person exam required? No—telehealth consultation suffices
• Special restrictions: Florida bans telehealth prescribing of Schedule II controlled substances (with narrow exceptions for psychiatric care, inpatient, hospice, or nursing home settings)
• Non-controlled meds: No restrictions on telehealth prescribing of trazodone, doxepin, or similar medications

Florida’s restrictions apply to highly controlled substances but don’t affect the most commonly prescribed telehealth insomnia treatments.

New York: Recent Regulatory Updates

• In-person exam required? Not for non-controlled medications
• Controlled substances: New York finalized rules in May 2025 limiting controlled substance prescribing via telehealth (30-day supply limits without in-person exam), but these rules don’t apply to non-controlled sleep aids
• Provider scope: NPs have independent practice authority after completing supervised practice hours

New Hampshire: Progressive Telehealth Legislation

• In-person exam required? No—Senate Bill 252 (effective August 2025) explicitly removed any prior in-person examination requirement
• Follow-up requirements: Providers must conduct appropriate follow-ups at least annually
• Provider authority: NPs have full practice authority; PAs work under collaborative agreements

New Hampshire’s 2025 law represents one of the most progressive telehealth frameworks in the country.

Alabama: Periodic In-Person Evaluation Required

• In-person exam required? Yes, but only periodically—after four telehealth visits for the same condition within one year, patients must be referred for an in-person evaluation within 12 months
• Rationale: Ensures patients receive comprehensive physical examinations for ongoing conditions
• Impact: Most insomnia patients can still access initial treatment entirely via telehealth, with in-person follow-up only after extended virtual-only care

Other States

Delaware, Georgia, and the vast majority of other states permit telehealth prescribing of non-controlled insomnia medications. State medical boards have generally embraced telemedicine as meeting professional standards of care, provided the evaluation is thorough and documented.

Key takeaway: You can access insomnia treatment via telehealth in every U.S. state, though specific procedural requirements vary. Reputable platforms like Klarity Health ensure their providers are licensed in your state and follow all applicable regulations.

Can Nurse Practitioners and Physician Assistants Prescribe Sleep Medications via Telehealth?

Yes, but the level of independence varies significantly by state.

Independent Practice States

In states with full practice authority for nurse practitioners—including New Hampshire, New York (after supervised hours), Delaware (after experience), and about 27 states total as of 2025—NPs can evaluate insomnia patients and prescribe medications entirely independently via telehealth.

Physician assistants typically require supervisory agreements even in these states, though the supervision may be remote and administrative rather than case-by-case oversight.

Collaborative Practice States

Most states, including Texas, Florida, California (transitioning to independence for qualified NPs), Georgia, and Alabama, require nurse practitioners and physician assistants to work under collaborative agreements or standardized procedures with physicians.

What this means for patients:

• You may see an NP or PA for your telehealth visit, with a physician partner available for consultation or chart review
• The collaborative model doesn’t prevent access to care—NPs and PAs in these states routinely prescribe non-controlled insomnia medications under their delegation agreements
• In practice, you’ll often interact only with the NP or PA, who handles your evaluation and prescription

Restrictions on Controlled Substance Prescribing

Even in collaborative states, NP and PA prescribing authority for controlled substances is often more limited. For example:

• Texas NPs cannot prescribe Schedule II drugs outside hospital or hospice settings
• Georgia and Alabama prohibit NPs/PAs from prescribing any Schedule II medications
• Many states restrict PA controlled substance prescribing

However, these restrictions do not affect non-controlled insomnia medications like trazodone or doxepin, which NPs and PAs can prescribe in all states (with appropriate collaborative agreements where required).

Klarity Health’s approach: We ensure our psychiatric nurse practitioners and other providers work within their state scope of practice, with physician collaboration in place where state law requires it. This allows us to offer consistent, accessible care regardless of where you live.

What to Expect During Your Telehealth Insomnia Consultation

The Initial Evaluation

A legitimate telehealth insomnia consultation is not just a quick questionnaire followed by a prescription. Expect a thorough evaluation that includes:

Sleep history assessment:

• How long you’ve had insomnia (chronic insomnia is defined as difficulty sleeping at least 3 nights per week for 3+ months)
• Sleep patterns: trouble falling asleep, staying asleep, or both
• What time you go to bed and wake up
• How long it takes you to fall asleep
• Whether you wake during the night and for how long
• Daytime impairment: fatigue, concentration problems, mood issues

Medical and psychiatric history:

• Current medications and supplements
• Past mental health conditions (depression, anxiety, PTSD)
• Medical conditions that could affect sleep (chronic pain, thyroid disorders, etc.)
• Previous sleep treatments tried
• Substance use (caffeine, alcohol, tobacco, recreational drugs)

Sleep hygiene evaluation:

• Bedroom environment (noise, light, temperature)
• Pre-bed routines and screen time
• Exercise habits and timing
• Shift work or irregular schedules

Screening for other sleep disorders:

• Symptoms of sleep apnea (snoring, gasping, witnessed breathing pauses)
• Restless legs syndrome
• Circadian rhythm disorders

Reputable providers will also screen for ‘red flag’ symptoms that require in-person evaluation rather than virtual treatment (more on this below).

Medication Discussion and Decision-Making

If medication is appropriate, your provider will discuss:

Treatment options:

• Why they’re recommending a specific medication
• How the medication works
• Expected timeline for improvement
• Potential side effects
• Drug interactions with your current medications

Non-pharmacological approaches:

• Sleep hygiene recommendations (often the first-line approach)
• Cognitive Behavioral Therapy for Insomnia (CBT-I)—considered the gold standard for chronic insomnia
• Relaxation techniques and stress management

Quality telehealth providers don’t simply prescribe pills. They understand that lasting insomnia improvement requires behavioral changes alongside any medication. Many platforms, including Klarity Health, integrate or recommend CBT-I resources or therapy referrals.

Prescription and Follow-Up

Initial prescription:

• Typically starts with a 30-day supply to assess response and side effects
• Sent electronically to your preferred pharmacy (e-prescribing is mandatory in many states including California and New York)
• Clear instructions on dosing, timing, and what to do if problems arise

Follow-up care:

• Most providers schedule a check-in within 2-4 weeks to assess effectiveness
• Follow-ups can be conducted via telehealth (phone or video)
• Adjustments to dose or medication can be made based on your response
• Refills authorized as appropriate, often for 90-day supplies once treatment is stable

Monitoring requirements:

• Some states (like New Hampshire) require at least annual follow-up evaluations for ongoing prescriptions
• Responsible providers will not simply authorize indefinite refills without periodic reassessment

What Telehealth Can and Cannot Do

Telehealth is appropriate for:

• Primary insomnia (not caused by another medical condition)
• Insomnia related to stress, anxiety, or mild depression
• Chronic insomnia in otherwise healthy adults
• Medication management for stable insomnia
• Sleep hygiene education and cognitive behavioral approaches

Telehealth has limitations for:

• Suspected sleep apnea (requires sleep study)
• Complex parasomnias (sleepwalking, night terrors)
• Narcolepsy or other rare sleep disorders requiring specialist evaluation
• Insomnia with serious underlying medical conditions requiring physical examination
• Situations requiring urgent or emergency care

When Telehealth Isn’t Appropriate: Red Flags Requiring In-Person Care

While telehealth is suitable for many insomnia cases, certain symptoms warrant immediate in-person evaluation:

Emergency Red Flags (Seek urgent care or ER)

• Chest pain or difficulty breathing accompanying insomnia
• Sudden confusion or altered mental status
• Severe headaches with sleep disturbance
• Thoughts of self-harm or suicide
• Hallucinations or delusions

Symptoms Requiring In-Person Specialist Evaluation

• Heavy snoring with witnessed breathing pauses (suggests sleep apnea)
• Excessive daytime sleepiness despite adequate sleep opportunity (could indicate narcolepsy or severe sleep apnea)
• Abnormal movements during sleep reported by bed partner
• Sleepwalking or other parasomnias in adults
• Insomnia starting after a head injury
• Rapidly progressive or severe insomnia not responding to treatment

Medical Conditions That Complicate Telehealth Treatment

• Untreated or uncontrolled depression or bipolar disorder (requires psychiatric evaluation)
• Active substance use disorders
• Complex medical conditions requiring medication adjustments (e.g., multiple heart medications)
• Pregnancy (medication options are limited; requires specialized obstetric input)
• Chronic pain conditions inadequately controlled

A responsible telehealth provider will recognize these situations and refer you to appropriate in-person care. This is a sign of quality, not a limitation. Platforms that promise to prescribe to anyone without proper screening are potentially engaging in inappropriate practice.

Insurance, Costs, and Access: What to Expect

Insurance Coverage for Telehealth

Most insurance plans now cover telehealth visits at parity with in-person appointments, a change solidified during the pandemic and extended through 2025 for Medicare and most private insurers.

What’s typically covered:

• The virtual consultation itself (billed as a telemedicine visit)
• Medication costs (if the prescribed drug is on your plan’s formulary)
• Follow-up appointments

What to verify:

• Whether your specific insurance plan is accepted by the telehealth platform
• Your copay or coinsurance for virtual visits
• Whether prior authorization is needed for sleep medications
• Pharmacy coverage and preferred drug tiers

Out-of-Pocket Costs

If you’re paying cash or if insurance doesn’t cover the service:

Visit costs typically range from $99-$199 for an initial consultation, with follow-ups sometimes less expensive.

Medication costs:

• Generic trazodone: $4-$20/month without insurance
• Generic doxepin: $10-$30/month without insurance
• Prices vary significantly by pharmacy—use discount cards like GoodRx for comparison

Klarity Health’s transparent pricing: We accept both insurance and cash pay, with clear upfront pricing. Our model includes access to licensed psychiatric providers (including psychiatrists and psychiatric nurse practitioners) who can address insomnia alongside any co-occurring anxiety or depression—common contributors to sleep problems. Appointments are typically available within 24-48 hours, eliminating the weeks-long waits common with traditional psychiatry.

Prescription Monitoring and Refills

Non-controlled medications like trazodone and doxepin:

• Not tracked in state Prescription Drug Monitoring Programs (PDMPs) in most states
• Refills can be authorized for up to 12 months in many cases
• Pharmacies can fill these without special procedures

Controlled substances (if prescribed):

• Reported to state PDMP databases
• Providers may check PDMP before prescribing (required for controlled substances in many states, optional for others)
• Stricter refill procedures
• Some states limit quantity per prescription

Most telehealth platforms focus on non-controlled options to streamline the process and avoid PDMP complexities, unless controlled substances are clearly medically necessary.

The Future of Telehealth Insomnia Treatment

What’s Coming in 2026

The DEA is expected to finalize new telemedicine prescribing rules in 2026, likely requiring:

• A ‘special telemedicine registration’ for providers prescribing controlled substances online
• Possible in-person examination requirements after an initial grace period (30-day supply) for some controlled medications
• Permanent framework replacing temporary COVID-era waivers

Impact on insomnia treatment: These changes will primarily affect controlled substance prescribing (Ambien, Lunesta, benzodiazepines). Non-controlled medications like trazodone and doxepin will remain fully accessible via telehealth regardless of DEA rule changes, since they fall outside the Ryan Haight Act’s scope.

State Legislative Trends

• Expanded NP independence: More states are moving toward full practice authority for experienced nurse practitioners, improving access to care
• Telehealth parity laws: Most states have made permanent the insurance coverage requirements for telemedicine
• Interstate licensure compacts: Growing participation in medical and nursing compacts makes it easier for providers to serve patients across state lines
• Integration with in-person care: Emerging ‘hybrid’ models where telehealth serves as entry point, with seamless referral to in-person specialists when needed

Technology and Treatment Evolution

• AI-assisted screening: Better tools to identify patients appropriate for telehealth vs. in-person care
• Digital CBT-I programs: Increased integration of evidence-based sleep therapy apps with medication management
• Wearable sleep monitoring: Data from devices like Oura Ring or Apple Watch informing treatment decisions
• Asynchronous care options: Some states considering approval of questionnaire-based evaluations for low-risk prescriptions

How Klarity Health Makes Insomnia Treatment Accessible

At Klarity Health, we’ve designed our platform to address the real barriers people face when seeking help for sleep problems:

Provider Availability When You Need It

Traditional sleep specialists often have wait times of 2-3 months. Our psychiatric providers, including board-certified psychiatrists and psychiatric nurse practitioners, typically have appointments available within 24-48 hours. Because insomnia often worsens with stress about the insomnia itself, quick access matters.

Expertise in Co-Occurring Conditions

Insomnia rarely exists in isolation. Our providers specialize in mental health, meaning they can address:

• Anxiety that’s keeping you awake
• Depression that disrupts sleep patterns
• ADHD that makes your mind race at bedtime
• PTSD-related nightmares and hypervigilance
• Stress-related sleep disruption

This integrated approach means you’re not just getting a sleep prescription—you’re receiving comprehensive care that addresses the root causes of your insomnia.

Transparent Pricing and Insurance Flexibility

We accept both insurance and cash pay, with:

• Clear upfront costs (no surprise bills)
• Insurance verification before your appointment
• Affordable self-pay rates for those without coverage or high deductibles
• Access to both prescribers and therapists under one platform

Continuity of Care

Insomnia treatment isn’t a one-time prescription. Our model includes:

• Easy follow-up scheduling (virtual or phone)
• Medication adjustments as needed
• Integration with therapy services (many insomnia patients benefit from CBT-I or addressing underlying anxiety)
• Ongoing support as long as you need it

Compliance and Quality

We ensure all providers:

• Are licensed in your state
• Follow state-specific prescribing regulations
• Work within their scope of practice (with physician collaboration where state law requires)
• Document thorough evaluations
• Screen appropriately for conditions requiring in-person care

Making an Informed Decision: Is Telehealth Right for Your Insomnia?

Good Candidates for Telehealth Insomnia Treatment

You’re likely a good fit for virtual care if you:

• Have chronic primary insomnia (difficulty sleeping without clear medical cause)
• Experience stress- or anxiety-related sleep problems
• Have tried sleep hygiene improvements without sufficient relief
• Don’t have symptoms suggesting sleep apnea or other complex disorders
• Are generally healthy without multiple complex medical conditions
• Want to try non-controlled medications first
• Prefer the convenience and privacy of virtual care

When to Start with In-Person Care

Consider seeing a sleep specialist or primary care doctor in person if you:

• Have never been evaluated for sleep problems before and have complex medical history
• Show signs of sleep apnea (loud snoring, gasping, witnessed pauses in breathing)
• Experience extreme daytime sleepiness or falling asleep uncontrollably
• Have parasomnia behaviors (sleepwalking, acting out dreams)
• Have had insomnia for years despite multiple treatment attempts
• Have serious psychiatric conditions requiring specialized care

Questions to Ask Before Choosing a Platform

Not all telehealth services are created equal. Before signing up, ask:

• What types of providers will I see? (MD/DO psychiatrists, psychiatric NPs, etc.)
• How long are appointments? (Rushed 10-minute visits vs. thorough evaluations)
• What if I need in-person care? (Do they have referral pathways?)
• How do refills work? (Easy process vs. requiring new appointments each time)
• Can I see the same provider consistently? (Continuity matters for ongoing care)
• What’s the cancellation policy?
• Do they prescribe controlled substances if needed, or only non-controlled medications?

Taking the Next Step Toward Better Sleep

Chronic insomnia is more than an inconvenience—it affects your physical health, mental wellbeing, work performance, and relationships. The good news is that effective treatment is more accessible than ever through telehealth.

Key takeaways to remember:

1. Telehealth prescribing of insomnia medication is legal nationwide for non-controlled medications like trazodone and doxepin
2. No federal in-person exam requirement exists for these medications, though state requirements vary slightly
3. Quality matters more than speed—choose providers who conduct thorough evaluations, not just prescription mills
4. Medication is most effective combined with behavioral strategies like CBT-I and sleep hygiene
5. Current telehealth flexibilities are stable through 2025, with non-controlled options remaining accessible regardless of future DEA rules

If you’ve been putting off getting help for insomnia because you can’t fit another appointment into your schedule, can’t afford traditional specialist visits, or simply feel uncomfortable discussing sleep problems in person, telehealth offers a legitimate, effective alternative.

Ready to Sleep Better?

Klarity Health’s psychiatric providers are available to evaluate your insomnia and create a personalized treatment plan—usually with appointments available in 24-48 hours. We combine medication management when appropriate with therapy referrals and evidence-based sleep strategies, all delivered through convenient virtual visits.

Get started today: Schedule your initial consultation and take the first step toward restful nights and energized days. We accept insurance and offer transparent cash-pay pricing, with no long-term commitments required.

References

1. U.S. Drug Enforcement Administration. (2024, November 15). DEA and HHS extend telemedicine flexibilities through 2025. Retrieved from https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. National Law Review – Sheppard Mullin. (2025, August 15). Telehealth and in-person visits: Tracking federal and state updates from pandemic-era. Retrieved from https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

3. Center for Connected Health Policy (CCHP). (2025, November). Online prescribing state laws and policy tracking. Retrieved from https://www.cchpca.org/topic/online-prescribing/

4. California Board of Registered Nursing. (2025). AB 890: Advanced Practice Registered Nurses practicing without standardized procedures. Retrieved from https://rn.ca.gov/practice/ab890.shtml

5. Healthcare Finance News. (2024, November 18). Telehealth prescribing of controlled drugs extended through 2025 (S. Morse). Retrieved from https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific health concerns and treatment options. Insomnia can have serious underlying causes that require professional evaluation.

Source:

• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=For%20the%20third%20time%2C%20the,medications%20and%20certain%20narcotic%20drugs
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=We%20continue%20to%20carefully%20consider,HHS%20on%20November%2015%2C%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=1,long%20as%20the%20issuing%20provider
• https://rn.ca.gov/practice/ab890.shtml#:~:text=Practicing%20Without%20Standardized%20Procedures%20in,103%20NP
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=A%20free%20standing%20emergency%20department,32%20Back%20to
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=5,7
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,registration%20but%20I%20do%20not
• https://www.cchpca.org/topic/online-prescribing/#:~:text=A%20telehealth%20provider%20may%20use,care%20services%20to%20the%20patient
• https://www.cchpca.org/topic/online-prescribing/#:~:text=A%20telehealth%20provider%20may%20not,is%20prescribed%20for%20the%20following